← All candidates
147 insider filings on record.
147 filings on record.
JAZZJazz Pharmaceuticals plc
NasdaqGS · Healthcare · $15.63B
$240.83
-2.05% · Sep 15
147 insider filings on record.
None of them an open-market buy in the last year.
Price · 1Y · daily● 46 sells◆ 4 8-K
▸ hover a marker for the filing · drag to zoom · daily bars sharpen to 30-min on close ranges · 4 moves explained
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$15.63B
Float
63.0M
97% public
Short % float
Pro
Price / profit
16.8
Price / future profit
9.3
Price / sales
3.4
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
142 more transactions on Pro →Context
Wall St
$257.00 avg target
+6.7% vs today · 19 analysts · consensus Buy
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
Earnings · EPS vs forecast
3 of 4 quarters beat
Q1 '26$6.34 act+$1.68
Q4 '25$6.64 act+$0.13
Q3 '25$8.13 act+$2.28
Q2 '25−$8.25 act−$2.00
Coverage
Jazz Pharmaceuticals Investors Eye Ziihera Launch in GEA as Key Driver, UBS SaysMT Newswires · 07-02Jazz Pharmaceuticals (JAZZ) Stock Gets Fair Value Boost As Ziihera Views Split AnalystsSimply Wall St. · 06-24Jazz Pharmaceuticals (JAZZ) Expands AbCellera Tie Up As Zepzelca Trial Misses GoalSimply Wall St. · 06-24Jazz Pharmaceuticals and AbCellera Biologics Inc. (ABCL) Announce CollaborationInsider Monkey · 06-23
The file stays open
147 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice